329 related articles for article (PubMed ID: 19215254)
1. Chronologic change of the maximum dimension of Bacillus Calmette-Guerin-induced keloids.
Tosa M; Murakami M; Ghazizadeh M; Hyakusoku H
Dermatol Surg; 2009 Feb; 35(2):189-94. PubMed ID: 19215254
[TBL] [Abstract][Full Text] [Related]
2. Role of vascular endothelial growth factor in keloids: a clinicopathologic study.
Salem A; Assaf M; Helmy A; Nofal A; Ibrahim S; Eldeeb F; Youssef C
Int J Dermatol; 2009 Oct; 48(10):1071-7. PubMed ID: 19775400
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R; Kaasinen E; Sankila A; Rintala E;
Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
[TBL] [Abstract][Full Text] [Related]
5. Relationship between age of ear piercing and keloid formation.
Lane JE; Waller JL; Davis LS
Pediatrics; 2005 May; 115(5):1312-4. PubMed ID: 15867040
[TBL] [Abstract][Full Text] [Related]
6. Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy.
Heiner JG; Terris MK
Urol Oncol; 2008; 26(2):137-40. PubMed ID: 18312931
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of hypertrophic and keloid scars according to the site of administration of intradermal BCG vaccine].
Orges González I
Bol Oficina Sanit Panam; 1980 Jun; 88(6):481-8. PubMed ID: 6448062
[No Abstract] [Full Text] [Related]
8. Comparative study of keloid formation in humans and laboratory animals.
Khorshid FA
Med Sci Monit; 2005 Jul; 11(7):BR212-9. PubMed ID: 15990682
[TBL] [Abstract][Full Text] [Related]
9. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study.
Kontochristopoulos G; Stefanaki C; Panagiotopoulos A; Stefanaki K; Argyrakos T; Petridis A; Katsambas A
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):474-9. PubMed ID: 15761426
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
Nazir Z; Qazi SH
J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
[TBL] [Abstract][Full Text] [Related]
11. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors.
Viani GA; Stefano EJ; Afonso SL; De Fendi LI
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1510-6. PubMed ID: 19101094
[TBL] [Abstract][Full Text] [Related]
12. Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
Boorjian SA; Berglund RK; Maschino AC; Savage CJ; Herr HW
J Urol; 2009 Oct; 182(4):1306-12. PubMed ID: 19683284
[TBL] [Abstract][Full Text] [Related]
13. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
Cerdá de Palou E; de Santy HP
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
[TBL] [Abstract][Full Text] [Related]
14. Treatment of keloids and hypertrophic scars using bleom.
Aggarwal H; Saxena A; Lubana PS; Mathur RK; Jain DK
J Cosmet Dermatol; 2008 Mar; 7(1):43-9. PubMed ID: 18254811
[TBL] [Abstract][Full Text] [Related]
15. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.
Bisiaux A; Thiounn N; Timsit MO; Eladaoui A; Chang HH; Mapes J; Mogenet A; Bresson JL; Prié D; Béchet S; Baron C; Sadorge C; Thomas S; Albert EB; Albert PS; Albert ML
J Urol; 2009 Apr; 181(4):1571-80. PubMed ID: 19230924
[TBL] [Abstract][Full Text] [Related]
16. Keloid scars--an avoidable complication of vaccination.
Moss A
Acta Paediatr; 2008 Jun; 97(6):690-1. PubMed ID: 18397346
[No Abstract] [Full Text] [Related]
17. [Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72].
Liu Y; Gao J; Liu X; Lu F; Liu H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Dec; 22(12):1433-6. PubMed ID: 19137883
[TBL] [Abstract][Full Text] [Related]
18. [Intra-keloid excision and deferred corticoid infiltration in the treatment of keloids. University Hospital Center of Treichville-Abidjan].
Richard-Kadio M; Dick R; Malan E; Kossoko H; Keli E; Yapo P; Kangah JM; N'Guessan AH; Cornet L
Med Trop (Mars); 1990; 50(3):279-85. PubMed ID: 2263183
[TBL] [Abstract][Full Text] [Related]
19. [Contraindication of operations for keloid scars occurring after BCG administration].
Lebedeva LV; Nikolaeva NV
Khirurgiia (Mosk); 1981 Jun; (6):73-5. PubMed ID: 7253461
[No Abstract] [Full Text] [Related]
20. Bacillus Calmette-Guérin vaccine-induced lupus vulgaris in a child adopted from China.
Samuel A; Browning J; Campbell J; Metry D
Pediatr Dermatol; 2007; 24(5):E44-6. PubMed ID: 17958779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
